{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:27:26Z","timestamp":1792020446200,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T00:00:00Z","timestamp":1545868800000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["DK106912"],"award-info":[{"award-number":["DK106912"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK056943"],"award-info":[{"award-number":["DK056943"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK056956"],"award-info":[{"award-number":["DK056956"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK056957"],"award-info":[{"award-number":["DK056957"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK056961"],"award-info":[{"award-number":["DK056961"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-1182-0","type":"journal-article","created":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T04:24:47Z","timestamp":1545884687000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8784-0509","authenticated-orcid":false,"given":"Katelyn A.","family":"McKenzie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirelle","family":"El Ters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente E.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene B.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Mrug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic F.","family":"Rahbari-Oskoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyongtae Ty","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas P.","family":"Landsittel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S. L.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Mahnken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,27]]},"reference":[{"issue":"14","key":"1182_CR1","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","volume":"359","author":"JJ Grantham","year":"2008","unstructured":"Grantham JJ. Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med. 2008;359(14):1477\u201385.","journal-title":"N Engl J Med"},{"key":"1182_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/CEOR.S76269","volume":"7","author":"SM Brunelli","year":"2015","unstructured":"Brunelli SM, et al. End-stage renal disease in autosomal dominant polycystic kidney disease: a comparison of dialysis-related utilization and costs with other chronic kidney diseases. Clinicoecon Outcomes Res. 2015;7:65\u201372.","journal-title":"Clinicoecon Outcomes Res"},{"issue":"2","key":"1182_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/ki.2009.128","volume":"76","author":"VE Torres","year":"2009","unstructured":"Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int. 2009;76(2):149\u201368.","journal-title":"Kidney Int"},{"key":"1182_CR4","unstructured":"US Food and Drug Administration. Drug Approval Package: Jynarque (tolvaptan). 2018; Available from: \n                    https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2018\/204441Orig1s000TOC.cfm\n                    \n                  . Accessed Oct 2018."},{"issue":"3","key":"1182_CR5","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/j.1523-1755.2004.00843.x","volume":"66","author":"FA Belibi","year":"2004","unstructured":"Belibi FA, et al. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int. 2004;66(3):964\u201373.","journal-title":"Kidney Int"},{"issue":"6","key":"1182_CR6","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1681\/ASN.2013101037","volume":"25","author":"MM Rinschen","year":"2014","unstructured":"Rinschen MM, Schermer B, Benzing T. Vasopressin-2 receptor signaling and autosomal dominant polycystic kidney disease: from bench to bedside and back again. J Am Soc Nephrol. 2014;25(6):1140\u20137.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"1182_CR7","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1097\/01.ASN.0000025282.48298.7B","volume":"13","author":"FA Belibi","year":"2002","unstructured":"Belibi FA, et al. The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2002;13(11):2723\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1182_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2015.59","volume":"88","author":"AB Chapman","year":"2015","unstructured":"Chapman AB, et al. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2015;88(1):17\u201327.","journal-title":"Kidney Int"},{"issue":"5","key":"1182_CR9","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1053\/ajkd.2001.28614","volume":"38","author":"GA Tanner","year":"2001","unstructured":"Tanner GA, Tanner JA. Chronic caffeine consumption exacerbates hypertension in rats with polycystic kidney disease. Am J Kidney Dis. 2001;38(5):1089\u201395.","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"1182_CR10","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1590\/S0100-879X2012007500120","volume":"45","author":"LC Vendramini","year":"2012","unstructured":"Vendramini LC, et al. Caffeine intake by patients with autosomal dominant polycystic kidney disease. Braz J Med Biol Res. 2012;45(9):834\u201340.","journal-title":"Braz J Med Biol Res"},{"key":"1182_CR11","doi-asserted-by":"crossref","unstructured":"Girardat-Rotar L, et al. Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a prospective longitudinal cohort study. J Nephrol. 2018;31(1):87\u201394.","DOI":"10.1007\/s40620-017-0396-8"},{"issue":"4","key":"1182_CR12","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/00004728-200007000-00019","volume":"24","author":"KT Bae","year":"2000","unstructured":"Bae KT, Commean PK, Lee J. Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease. J Comput Assist Tomogr. 2000;24(4):614\u20139.","journal-title":"J Comput Assist Tomogr"},{"issue":"3","key":"1182_CR13","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","volume":"64","author":"AB Chapman","year":"2003","unstructured":"Chapman AB, et al. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the consortium for radiologic imaging studies of polycystic kidney disease (CRISP) cohort. Kidney Int. 2003;64(3):1035\u201345.","journal-title":"Kidney Int"},{"issue":"4","key":"1182_CR14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2215\/CJN.03750708","volume":"4","author":"KT Bae","year":"2009","unstructured":"Bae KT, et al. MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement. Clin J Am Soc Nephrol. 2009;4(4):719\u201325.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"20","key":"1182_CR15","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa054341","volume":"354","author":"JJ Grantham","year":"2006","unstructured":"Grantham JJ, et al. Volume progression in polycystic kidney disease. N Engl J Med. 2006;354(20):2122\u201330.","journal-title":"N Engl J Med"},{"issue":"3","key":"1182_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2215\/CJN.09500911","volume":"7","author":"AB Chapman","year":"2012","unstructured":"Chapman AB, et al. Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2012;7(3):479\u201386.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"1182_CR17","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1681\/ASN.2009020171","volume":"20","author":"LA Stevens","year":"2009","unstructured":"Stevens LA, Levey AS. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol. 2009;20(11):2305\u201313.","journal-title":"J Am Soc Nephrol"},{"key":"1182_CR18","unstructured":"US Department of Agriculture, A.R.S., nutrient data laboratory. USDA National Nutrient Database for standard reference, release 28 (slightly revised). Version Current: May 2016. Beverages, coffee, brewed, prepared with tap water. Internet: \n                    https:\/\/ndb.nal.usda.gov\/ndb\/foods\/show\/14209\n                    \n                  . Accessed June 2016."},{"key":"1182_CR19","unstructured":"Caffeine in food. 2012. Available from: from: \n                    https:\/\/www.canada.ca\/en\/health-canada\/services\/food-nutrition\/food-safety\/food-additives\/caffeine-foods\/foods.html\n                    \n                  . Accessed June 2016."},{"issue":"3","key":"1182_CR20","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1681\/ASN.2015010016","volume":"27","author":"E Cornec-Le Gall","year":"2016","unstructured":"Cornec-Le Gall E, et al. The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2016;27(3):942\u201351.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"1182_CR21","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1681\/ASN.2015050583","volume":"27","author":"CM Heyer","year":"2016","unstructured":"Heyer CM, et al. Predicted mutation strength of nontruncating PKD1 mutations aids genotype-phenotype correlations in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2016;27(9):2872\u201384.","journal-title":"J Am Soc Nephrol"},{"key":"1182_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/9781118625590","volume-title":"Applied regression analysis","author":"NR Draper","year":"1998","unstructured":"Draper NR, Smith H. Applied regression analysis. New York: Wiley; 1998."},{"issue":"3","key":"1182_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10157-012-0706-3","volume":"17","author":"A Ozkok","year":"2013","unstructured":"Ozkok A, et al. Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience. Clin Exp Nephrol. 2013;17(3):345\u201351.","journal-title":"Clin Exp Nephrol"},{"issue":"11","key":"1182_CR24","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1681\/ASN.2013111184","volume":"25","author":"RW Schrier","year":"2014","unstructured":"Schrier RW, et al. Predictors of autosomal dominant polycystic kidney disease progression. J Am Soc Nephrol. 2014;25(11):2399\u2013418.","journal-title":"J Am Soc Nephrol"},{"key":"1182_CR25","doi-asserted-by":"publisher","unstructured":"Wijarnpreecha K, et al. Association of coffee consumption and chronic kidney disease: a meta-analysis. Int J Clin Pract. 2017;71(1). \n                    https:\/\/doi.org\/10.1111\/ijcp.12919\n                    \n                  .","DOI":"10.1111\/ijcp.12919"},{"key":"1182_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12986-016-0144-4","volume":"13","author":"D Petrovic","year":"2016","unstructured":"Petrovic D, et al. Relation of 24-hour urinary caffeine and caffeine metabolite excretions with self-reported consumption of coffee and other caffeinated beverages in the general population. Nutr Metab (Lond). 2016;13:81.","journal-title":"Nutr Metab (Lond)"},{"issue":"4","key":"1182_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2125.1991.tb05553.x","volume":"31","author":"DJ Birkett","year":"1991","unstructured":"Birkett DJ, Miners JO. Caffeine renal clearance and urine caffeine concentrations during steady state dosing. Implications for monitoring caffeine intake during sports events. Br J Clin Pharmacol. 1991;31(4):405\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"1182_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/978-3-642-13443-2_15","volume":"200","author":"H Osswald","year":"2011","unstructured":"Osswald H, Schnermann J. Methylxanthines and the kidney. Handb Exp Pharmacol. 2011;200:391\u2013412.","journal-title":"Handb Exp Pharmacol"},{"issue":"5","key":"1182_CR29","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1042\/cs1030461","volume":"103","author":"DG Shirley","year":"2002","unstructured":"Shirley DG, Walter SJ, Noormohamed FH. Natriuretic effect of caffeine: assessment of segmental sodium reabsorption in humans. Clin Sci (Lond). 2002;103(5):461\u20136.","journal-title":"Clin Sci (Lond)"},{"issue":"10","key":"1182_CR30","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.2215\/CJN.03530411","volume":"6","author":"E Higashihara","year":"2011","unstructured":"Higashihara E, et al. Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience. Clin J Am Soc Nephrol. 2011;6(10):2499\u2013507.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1182_CR31","doi-asserted-by":"publisher","first-page":"e84154","DOI":"10.1371\/journal.pone.0084154","volume":"9","author":"SC Killer","year":"2014","unstructured":"Killer SC, Blannin AK, Jeukendrup AE. No evidence of dehydration with moderate daily coffee intake: a counterbalanced cross-over study in a free-living population. PLoS One. 2014;9(1):e84154.","journal-title":"PLoS One"},{"issue":"5","key":"1182_CR32","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jsams.2014.07.017","volume":"18","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, et al. Caffeine and diuresis during rest and exercise: a meta-analysis. J Sci Med Sport. 2015;18(5):569\u201374.","journal-title":"J Sci Med Sport"},{"issue":"4","key":"1182_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1056\/NEJM197801262980403","volume":"298","author":"D Robertson","year":"1978","unstructured":"Robertson D, et al. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med. 1978;298(4):181\u20136.","journal-title":"N Engl J Med"},{"issue":"4","key":"1182_CR34","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3945\/ajcn.111.016667","volume":"94","author":"AE Mesas","year":"2011","unstructured":"Mesas AE, et al. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr. 2011;94(4):1113\u201326.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"1182_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.maturitas.2013.02.002","volume":"75","author":"A Cano-Marquina","year":"2013","unstructured":"Cano-Marquina A, Tarin JJ, Cano A. The impact of coffee on health. Maturitas. 2013;75(1):7\u201321.","journal-title":"Maturitas"},{"issue":"1","key":"1182_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3945\/ajcn.111.018267","volume":"95","author":"G Renda","year":"2012","unstructured":"Renda G, et al. Genetic determinants of blood pressure responses to caffeine drinking. Am J Clin Nutr. 2012;95(1):241\u20138.","journal-title":"Am J Clin Nutr"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1182-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-1182-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1182-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T14:39:40Z","timestamp":1589467180000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-1182-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1182"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-1182-0","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"19 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Each participant in the CRISP study signed an informed consent to participate in the study. The study was approved by the Institutional Review Board (IRB) at the University of Kansas Medical Center (STUDY00141151).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No individual level data was presented in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"VET, PCH and MM have received research funding from Otsuka Pharmaceuticals. FFR is a consultant for Keryx and Kadmon and has received research funding from Otsuka and Genzyme. ABC is a consultant for Otsuka, Pfizer and Sanofi, and has received research funding from Boston Scientific, Kadmon and Otsuka.\u00a0MM is also a consultant for Otsuka and Sanofi. All other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"378"}}